Sidmak Laboratories

Sidmak Laboratories is a pharmaceutical company specializing in the development and manufacture of generic drug products and providing contract development and manufacturing services (CDMO). Founded in 1978, the company established a strong reputation for its expertise in solid oral dosage forms, including sustained-release and immediate-release formulations. The company was a pioneer in the generic drug industry, particularly in the United States, where it successfully navigated the ANDA process for complex formulations. In 2008, its U.S. operations were acquired by Plethico Pharmaceuticals, though the Sidmak brand continues to operate through its Indian entity. Today, the company provides a range of services from formulation development to commercial-scale manufacturing for global markets. Its facilities are equipped to handle various therapeutic categories, with a focus on high-quality, cost-effective medication.